The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to demonstrate the efficacy and safety of dabigatran etexilate
and different intensity warfarin for the prevention of stroke and systemic embolism in
patients with non-valvular atrial fibrillation.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University